# The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial

Study · id `cardio:ct-nct00784433` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00784433](<https://clinicaltrials.gov/study/NCT00784433>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00784433

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 224 participants.

## Technical summary

Registry record NCT00784433. Randomized; no masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2012-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 224 participants (enrolled count; ClinicalTrials.gov record NCT00784433, source copy `cardio:ctgov-nct00784433-2019-07-15`, retrieved 2026-10-26)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT00784433, source copy `cardio:ctgov-nct00784433-2019-07-15`, retrieved 2026-10-26)
- Primary completion: 2012-05 (actual) (ClinicalTrials.gov record NCT00784433, source copy `cardio:ctgov-nct00784433-2019-07-15`, retrieved 2026-10-26)
- Completion: 2012-05 (actual) (ClinicalTrials.gov record NCT00784433, source copy `cardio:ctgov-nct00784433-2019-07-15`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00784433-2019-07-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial
- Acronym: CASCADE
- Condition: Diabetes
- Condition: Prediabetes
- Intervention (Dietary supplement): alcohol
- Lead sponsor: Ben-Gurion University of the Negev
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial (`cardio:pubmed-26458258`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Differential Effect of Initiating Moderate Red Wine Consumption on 24-h Blood Pressure by Alcohol Dehydrogenase Genotypes: Randomized Trial in Type 2 Diabetes (`cardio:pubmed-26232779`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of initiating moderate wine intake on abdominal adipose tissue in adults with type 2 diabetes: a 2-year randomized controlled trial (`cardio:pubmed-27692023`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e0eead62b3ea24e23890ef8cadc46e6dfdae18bb9d3e2d015160617503337146
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
